Biotech Values

[mcbio]

Investors Overplay JAK Threat to Abbott's Humira

But do they underplay the SYK threat? LOL jk Nice article. ABT will still get theirs I'm sure. And there should still be a nice market for PFE, AZN/RIGL, and others if the JAK/SYK drugs get approved.